Nectero EAST System Clinical Study
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Nectero Medical, Inc.
- Study ID
- NCT06001918
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Abdominal Aortic Aneurysm
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nectero EAST System — DRUGTreated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug.
Study Details
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Key Dates
- Start date
- Oct 25, 2023
- Status verified
- May 2026
- Primary completion
- Jun 30, 2028
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment ArmParticipants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer
- No Intervention: Control ArmParticipants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years.
Primary Outcome Measure
Primary Endpoint [ Time Frame: 24 months ]
Central Contacts
- Charlene Knape866-755-4744
- Tracy Roberts(303)3964603
Locations (37)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Honor Health Scottsdale Shea Medical Center | Scottsdale | Arizona | 85258 | HonorHealth Cardiovascular Research 480-323-1046 Hasan Aldailami, MD (PRINCIPAL_INVESTIGATOR) |
| University of Colorado | Aurora | Colorado | 80045 | - |
| Medstar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | Steven Abramowitz, MD (PRINCIPAL_INVESTIGATOR) |
| Prime Vascular Institute | Delray Beach | Florida | 33446 | - |
| Medical College of Georgia | Augusta | Georgia | 30912 | Natasha Flores William Jordan, MD (PRINCIPAL_INVESTIGATOR) |
| University of Chicago | Chicago | Illinois | 60637 | Susana Lopez Ross Milner, MD (PRINCIPAL_INVESTIGATOR) |
| MaineMed Vascular Surgery | Scarborough | Maine | 04074 | Kathryn Ackermann Kristina Giles, MD (PRINCIPAL_INVESTIGATOR) |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | Fernando Moreno Marc Schermerhorn, MD (PRINCIPAL_INVESTIGATOR) |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Kaitlin Gossart Nikolaos Zacharias, MD (PRINCIPAL_INVESTIGATOR) |
| University of Massachusetts | Worcester | Massachusetts | 01655 | Shauneen Valliere Andres Schanzer, MD (PRINCIPAL_INVESTIGATOR) |
| Beaumont Health | Royal Oak | Michigan | 48073 | Lisa Bliss Graham Long, MD (PRINCIPAL_INVESTIGATOR) |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Luis Sanchez, MD (PRINCIPAL_INVESTIGATOR) |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | Jarod Phillips Jonathan Thompson, MD (PRINCIPAL_INVESTIGATOR) |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | - |
| University of Rochester | Rochester | New York | 14642 | Mary Bourret Doran Mix, MD (PRINCIPAL_INVESTIGATOR) |
| Stony Brook Medicine | Stony Brook | New York | 11794 | Daria Shavarina Rabih Chaer, MD (PRINCIPAL_INVESTIGATOR) |
| Duke University Medical Center | Durham | North Carolina | 27710 | Chandler Long, MD (PRINCIPAL_INVESTIGATOR) |
| The Christ Hospital | Cincinnati | Ohio | 45219 | Jamie Elkins Geoff Answini, MD (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
| University Hospitals Cleveland | Cleveland | Ohio | 44106 | Amy Kluge Sheena Rees Jae Cho, MD (PRINCIPAL_INVESTIGATOR) |
| Ohio Health Riverside | Columbus | Ohio | 43214 | Regan Moran Joseph Campbell, MD (PRINCIPAL_INVESTIGATOR) |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | Kristine Orion, MD (PRINCIPAL_INVESTIGATOR) |
| Oklahoma Heart Institute | Tulsa | Oklahoma | 74104 | Tamara Morton Julia Chen, MD (PRINCIPAL_INVESTIGATOR) |
| Portland VA Medical Center | Portland | Oregon | 97239 | Rachel Nelson Matthew Koopmann, MD (PRINCIPAL_INVESTIGATOR) |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | 18015 | Sharvil Sheth, MD (PRINCIPAL_INVESTIGATOR) |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Grace Wang, MD (PRINCIPAL_INVESTIGATOR) |
| Jefferson Clinical Research Institute | Philadelphia | Pennsylvania | 19107 | Jona Shperdheja Michael Nooromid, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15219 | Judith Brimmeier Raymond Eid, MD (PRINCIPAL_INVESTIGATOR) |
| Prisma Health | Greenville | South Carolina | 29605 | Nikita Kasinger Maggie Salle Mark P Androes, MD (PRINCIPAL_INVESTIGATOR) |
| North Central Heart - A Division of Avera Heart Hospital | Sioux Falls | South Dakota | 57108 | Michael Bacharach, MD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Jennifer Scott Celia Nunez John Curci, MD (PRINCIPAL_INVESTIGATOR) |
| Houston Healthcare | Houston | Texas | 77004 | Swathi Potla Kristofer Charlton-Ouw, MD (PRINCIPAL_INVESTIGATOR) |
| Baylor Scott & White Medical Center | Plano | Texas | 75093 | Saba Arianpour William Shutze, MD (PRINCIPAL_INVESTIGATOR) |
| University of Utah Hospital | Salt Lake City | Utah | 84132 | Julie Hales Cali Johnson, MD (PRINCIPAL_INVESTIGATOR) |
| Inova Fairfax Medical Campus Inova Health Systems | Fairfax | Virginia | 22031 | Bhruga Shah Kendal Endicott, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington at Harborview Medical Center | Seattle | Washington | 98104 | Allison Larimore Benjamin Starnes, MD (PRINCIPAL_INVESTIGATOR) |
| Bellin Memorial Hospital | Green Bay | Wisconsin | 54301 | Katie Guilliam Jason Ricci, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
Related Studies
- Magnetic Resonance Elastography in Patients With Abdominal Aortic AneurysmsRecruiting · Ohio State University · Columbus, Ohio
- Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging TechniquesRecruiting · Mayo Clinic · Jacksonville, Florida
- Terumo Aortic Global Endovascular RegistryRecruiting · Vascutek Ltd. · Long Beach, California
- Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)Recruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts